Literature DB >> 11023868

Establishment of left/right asymmetry in neuroblast migration by UNC-40/DCC, UNC-73/Trio and DPY-19 proteins in C. elegans.

L Honigberg1, C Kenyon.   

Abstract

The bilateral C. elegans neuroblasts QL and QR are born in the same anterior/posterior (A/P) position, but polarize and migrate left/right asymmetrically: QL migrates toward the posterior and QR migrates toward the anterior. After their migrations, QL but not QR switches on the Hox gene mab-5. We find that the UNC-40/netrin receptor and a novel transmembrane protein DPY-19 are required to orient these cells correctly. In unc-40 or dpy-19 mutants, the Q cells polarize randomly; in fact, an individual Q cell polarizes in multiple directions over time. In addition, either cell can express MAB-5. Both UNC-40 and DPY-19, as well as the Trio/GTPase exchange factor homolog UNC-73, are required for full polarization and migration. Thus, these proteins appear to participate in a signaling system that orients and polarizes these migrating cells in a left/right asymmetrical fashion during development. The C. elegans netrin UNC-6, which guides many cells and axons along the dorsoventral axis, is not involved in Q cell polarization, suggesting that a different netrin-like ligand serves to polarize these cells along the anteroposterior axis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023868     DOI: 10.1242/dev.127.21.4655

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  46 in total

1.  Pitx2a expression alters actin-myosin cytoskeleton and migration of HeLa cells through Rho GTPase signaling.

Authors:  Qize Wei; Robert S Adelstein
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

2.  MIG-15 and ERM-1 promote growth cone directional migration in parallel to UNC-116 and WVE-1.

Authors:  Jérôme Teulière; Christelle Gally; Gian Garriga; Michel Labouesse; Elisabeth Georges-Labouesse
Journal:  Development       Date:  2011-10       Impact factor: 6.868

3.  UNC-73/trio RhoGEF-2 activity modulates Caenorhabditis elegans motility through changes in neurotransmitter signaling upstream of the GSA-1/Galphas pathway.

Authors:  Shuang Hu; Tony Pawson; Robert M Steven
Journal:  Genetics       Date:  2011-07-12       Impact factor: 4.562

4.  The fat-like cadherin CDH-4 acts cell-non-autonomously in anterior-posterior neuroblast migration.

Authors:  Lakshmi Sundararajan; Megan L Norris; Sebastian Schöneich; Brian D Ackley; Erik A Lundquist
Journal:  Dev Biol       Date:  2014-06-19       Impact factor: 3.582

5.  Interactions of UNC-34 Enabled with Rac GTPases and the NIK kinase MIG-15 in Caenorhabditis elegans axon pathfinding and neuronal migration.

Authors:  M Afaq Shakir; Jason S Gill; Erik A Lundquist
Journal:  Genetics       Date:  2005-10-03       Impact factor: 4.562

6.  Rho-guanine nucleotide exchange factors during development: Force is nothing without control.

Authors:  Shai Mulinari; Udo Häcker
Journal:  Small GTPases       Date:  2010-07

7.  Transmembrane proteins UNC-40/DCC, PTP-3/LAR, and MIG-21 control anterior-posterior neuroblast migration with left-right functional asymmetry in Caenorhabditis elegans.

Authors:  Lakshmi Sundararajan; Erik A Lundquist
Journal:  Genetics       Date:  2012-10-10       Impact factor: 4.562

8.  A C. elegans Myc-like network cooperates with semaphorin and Wnt signaling pathways to control cell migration.

Authors:  Christopher L Pickett; Kevin T Breen; Donald E Ayer
Journal:  Dev Biol       Date:  2007-08-03       Impact factor: 3.582

9.  Identification of genes that regulate a left-right asymmetric neuronal migration in Caenorhabditis elegans.

Authors:  QueeLim Ch'ng; Lisa Williams; Yung S Lie; Mary Sym; Jennifer Whangbo; Cynthia Kenyon
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

10.  Kalirin12 interacts with dynamin.

Authors:  Xiaonan Xin; Chana A Rabiner; Richard E Mains; Betty A Eipper
Journal:  BMC Neurosci       Date:  2009-06-17       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.